Alan R. Tall
Alan R. Tall publishes mostly in Surgery, Molecular Biology and Immunology, on topics such as Cholesterol and Lipid Metabolism, Diabetes, Cardiovascular Risks, and Lipoproteins and Peroxisome Proliferator-Activated Receptors.
- World rank
- #1,665 of 7,710,434 ranked researchers
- Rank in United States
- #655 of 1,627,098
- Works
- 476
- Citations
- 65k
- Citations per work
- 135.7
What does Alan R. Tall research?
Alan R. Tall's work is mostly in Medicine (36%), Biochemistry, Genetics and Molecular Biology (22%), Immunology and Microbiology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences16935.6%
- Medicine16935.6%
- Life Sciences15432.3%
- Everything else15332.1%
- 1Surgery21% of their works
- 2Molecular Biology16% of their works
- 3Immunology10% of their works
- 4Endocrinology, Diabetes and Metabolism8% of their works
- 5Oncology7% of their works
- 6Cancer Research6% of their works
Research topics
- Cholesterol and Lipid Metabolism
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Peroxisome Proliferator-Activated Receptors
- Lipoproteins and Cardiovascular Health
- Cancer, Lipids, and Metabolism
- Drug Transport and Resistance Mechanisms
- Lipid metabolism and biosynthesis
- Atherosclerosis and Cardiovascular Diseases
Which keywords describe Alan R. Tall's research?
The keywords of their largest research topics: Cholesterol, Atherosclerosis, Metabolism, LXR, SREBP, Diabetes, Obesity and Nuclear Receptors.
- Oxidized LDL
- Triacylglycerol Synthesis
- Multidrug Resistance
- Fatty Acid Synthase
- Cholesterol-lowering
- Peroxisome Proliferator-Activated Receptors
- Metabolic Syndrome
- Inflammation
- Nuclear Receptors
- Diabetes
- LXR
- Atherosclerosis
- Cholesterol
- Metabolism
- SREBP
- Obesity
- Statins
- Cardiovascular Disease
- PPARs
- Cardiovascular Disease Prevention
- ATP-dependent Transporters
- Lipid Metabolism
- Lipid Droplets
- Immune Response
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Cholesterol3513 topics
- Atherosclerosis3213 topics
- Metabolism2712 topics
- LXR1931 topic
- SREBP1931 topic
- Diabetes1612 topics
- Obesity1612 topics
- Nuclear Receptors1532 topics
- Statins1522 topics
- Inflammation1232 topics
- Cardiovascular Disease831 topic
- Metabolic Syndrome831 topic
- PPARs781 topic
- Peroxisome Proliferator-Activated Receptors781 topic
- Cardiovascular Disease Prevention771 topic
- Cholesterol-lowering771 topic
- ATP-dependent Transporters751 topic
- Fatty Acid Synthase751 topic
- Lipid Metabolism751 topic
- Multidrug Resistance751 topic
- Lipid Droplets491 topic
- Triacylglycerol Synthesis491 topic
- Immune Response451 topic
- Oxidized LDL451 topic
Where does Alan R. Tall work?
Alan R. Tall's main affiliation in the publication record is Columbia University, United States.
How many publications and citations does Alan R. Tall have?
OpenAlex counts 476 works and 64,613 citations for Alan R. Tall, an h-index of 133, ranking #1,665 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Alan R. Tall. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.